Safety and efficacy of coronary sinus narrowing in chronic refractory angina: Insights from the RESOURCE study

Refractory angina (RA) is considered the end-stage of coronary artery disease, and often has no interventional treatment options. Coronary sinus Reducer (CSR) is a recent addition to the therapeutic arsenal, but its efficacy has only been evaluated on small populations. The RESOURCE registry provides further insights into this therapy.

Source: International Journal of Cardiology - May 21, 2021 Category: Cardiology Authors: Francesco Ponticelli, Arif A. Khokhar, Geert Leenders, Maayan Konigstein, Carlo Zivelonghi, Pierfrancesco Agostoni, Jan-Peter van Kuijk, Issameddine Ajmi, Steven Lindsay, Matja ž Bunc, Matteo Tebaldi, Alessandro Cafaro, Kevin Cheng, Alfonso Ielasi, Tiffa Source Type: research